Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹15121 Cr.
Stock P/E
94.5
P/B
4.6
Current Price
₹1328.2
Book Value
₹ 290
Face Value
10
52W High
₹1415.4
52W Low
₹ 1031.8
Dividend Yield
0.11%

Anupam Rasayan India Overview

Business

Anupam Rasayan India Ltd. (ARIL) is a leading specialty chemical manufacturer in India, primarily engaged in custom synthesis and manufacturing of specialty chemicals for various end-user industries. The company focuses on highly complex, multi-step synthesis and differentiated chemicals. Its core business model involves developing and manufacturing advanced intermediates and active ingredients based on proprietary chemistries or customer-provided specifications. It generates revenue by supplying these specialty chemicals, often under long-term contracts, to global agrochemical, pharmaceutical, pigment, and personal care companies.

Revenue Mix

Anupam Rasayan's revenue is primarily derived from two broad segments:

Life Science Related Specialty Chemicals: This segment caters to agrochemicals (herbicides, fungicides, insecticides), pharmaceuticals, and animal health products. This is historically its dominant segment.

Other Specialty Chemicals: This segment includes specialty pigments, dyes, and chemicals for personal care products.

The company typically serves a mix of multinational corporations and domestic players, with a significant portion of its revenue derived from exports. Specific revenue contribution percentages for each segment are not constant but the life sciences segment typically accounts for a larger share.

Industry

The Indian specialty chemicals industry is characterized by its diversity, high growth potential, and increasing global prominence due to factors like cost-effectiveness, skilled manpower, and robust R&D capabilities. Anupam Rasayan operates in the niche of custom synthesis and manufacturing (CSM) of advanced intermediates and complex molecules. It is positioned as a reliable partner for global companies seeking to outsource complex chemical synthesis, particularly in agrochemicals and pharmaceuticals. Its positioning is strengthened by its focus on challenging chemistries, robust R&D, and ability to scale up production.

MOAT

Process Intensification & R&D Capabilities: Expertise in handling complex, hazardous, and multi-step reactions, supported by strong in-house R&D capabilities, allows it to develop and scale niche chemical processes.

Long-term Customer Relationships: Strong and sticky relationships with global customers, often spanning decades, due to consistent quality, reliability, and confidentiality in custom synthesis projects.

Diversified Product Portfolio: While focused on specialty chemicals, its products cater to multiple end-user industries, reducing dependence on a single sector.

Backward Integration: Strategic backward integration for key raw materials helps in cost optimization and supply chain stability.

Growth Drivers

Increasing Outsourcing Trend: Global chemical majors are increasingly outsourcing manufacturing of complex intermediates to Indian players, driven by cost efficiencies and environmental regulations in developed economies.

End-Market Growth: Growing demand from key end-user industries such as agrochemicals (for crop protection), pharmaceuticals (for new drug development), and pigments globally.

Capacity Expansion: Ongoing capital expenditure and expansion projects to meet growing demand and diversify product offerings.

New Product Development & Diversification: Focus on developing new molecules and expanding into newer specialty chemical segments, including electronic chemicals and personal care.

Risks

Raw Material Price Volatility: Fluctuations in crude oil prices and other key raw material costs can impact profitability, as it has limited ability to pass on all cost increases.

Client Concentration: While diversified, a significant portion of revenue may still come from a few large multinational clients, making it vulnerable to changes in their procurement strategies.

Regulatory & Environmental Risks: Strict environmental regulations, hazardous waste management, and potential changes in chemical policies can lead to increased compliance costs or operational disruptions.

Forex Fluctuations: A significant portion of revenue is export-oriented, making it susceptible to adverse currency movements.

Competition: Intense competition from domestic and international specialty chemical manufacturers.

Management & Ownership

Anupam Rasayan is a promoter-driven company. The Shah family are the promoters with Mr. Anand S. Desai and Mr. Milan S. Thakkar serving as Managing Directors. The promoters have a long history and deep understanding of the chemical industry, having been involved in specialty chemical manufacturing for several decades. Promoter holding typically reflects a significant stake, aligning their interests with the company's long-term growth. The management team includes experienced professionals in R&D, operations, and sales.

Outlook

Anupam Rasayan is well-positioned to capitalize on the secular growth trends in the Indian specialty chemicals sector, driven by global outsourcing and increasing demand from its key end-user industries. Its strong R&D capabilities, long-standing customer relationships, and strategic capacity expansions provide a robust foundation for future growth. However, the company faces potential headwinds from raw material price volatility, intense competition, and the inherent regulatory complexities of the chemical industry. While the company's focus on complex chemistries and diversification into new segments offers resilience, managing client concentration and effectively passing on input cost increases will be crucial for sustained profitability.

Anupam Rasayan India Share Price

Live · BSE / NSE · Inception: 2003
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Anupam Rasayan India Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 296 401 254 294 390 500 486 731 512 636
Other Income 2 12 6 2 -4 6 5 8 2 3
Total Income 298 413 260 296 387 506 491 739 515 639
Total Expenditure 216 308 201 214 266 356 362 596 385 498
Operating Profit 81 105 59 82 121 150 129 144 130 141
Interest 25 26 22 27 32 31 36 36 35 42
Depreciation 20 21 21 22 29 31 31 32 34 43
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 36 58 16 34 59 88 63 76 60 56
Provision for Tax 10 17 4 3 5 25 14 18 -1 0
Profit After Tax 26 40 12 31 54 63 48 57 61 56
Adjustments -8 -10 -8 -14 -26 -18 -14 -13 -12 -13
Profit After Adjustments 18 31 4 17 28 45 34 44 49 43
Adjusted Earnings Per Share 1.7 2.8 0.4 1.5 2.6 4.1 3.1 3.9 4.3 3.7

Anupam Rasayan India Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 288 288 343 501 529 811 1074 1602 1475 1437 2365
Other Income 8 11 6 20 17 27 7 9 30 16 18
Total Income 296 299 349 521 545 838 1081 1610 1505 1453 2384
Total Expenditure 208 218 268 408 400 617 769 1171 1094 1041 1841
Operating Profit 87 81 81 113 146 220 312 440 411 412 544
Interest 21 21 15 24 45 69 31 63 89 112 149
Depreciation 13 15 18 23 29 52 60 71 80 102 140
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 54 45 49 66 72 100 222 308 242 198 255
Provision for Tax 11 10 9 16 18 30 70 91 74 38 31
Profit After Tax 43 35 40 50 53 70 152 217 167 160 222
Adjustments 0 0 1 -1 0 0 0 -36 -39 -67 -52
Profit After Adjustments 43 35 41 49 53 70 152 181 129 93 170
Adjusted Earnings Per Share 8.5 7 8.2 9.8 10.6 7 15.2 16.8 11.7 8.5 15

Anupam Rasayan India Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 147 250 457 507 594 1573 1727 2373 2761 2850
Minority's Interest 0 0 0 0 0 0 0 135 170 231
Borrowings 164 223 268 462 525 247 494 355 197 171
Other Non-Current Liabilities 7 9 10 14 52 57 74 104 158 208
Total Current Liabilities 163 151 266 341 500 429 595 811 1316 1808
Total Liabilities 481 632 1001 1324 1670 2307 2891 3778 4602 5269
Fixed Assets 259 313 382 681 977 1115 1202 1417 1501 2185
Other Non-Current Assets 70 94 281 218 135 92 242 249 874 511
Total Current Assets 152 226 338 425 558 1099 1447 2111 2227 2573
Total Assets 481 632 1001 1324 1670 2307 2891 3778 4602 5269

Anupam Rasayan India Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 15 8 7 -2 17 241 48 188 250
Cash Flow from Operating Activities 69 17 -22 39 95 1 -171 292 59 -30
Cash Flow from Investing Activities -168 -93 -255 -250 -178 -193 -412 -523 -392 -330
Cash Flow from Financing Activities 115 73 277 206 102 416 384 371 395 223
Net Cash Inflow / Outflow 15 -3 -1 -6 19 224 -199 140 62 -137
Closing Cash & Cash Equivalent 15 12 7 2 17 241 42 188 250 113

Anupam Rasayan India Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 8.53 6.96 8.17 9.85 10.64 7.04 15.18 16.83 11.71 8.49
CEPS(Rs) 11.04 10.03 11.49 14.55 16.38 12.2 21.18 26.79 22.51 23.86
DPS(Rs) 0.5 0 0 0 0 0.5 1.5 2.5 1.25 0.75
Book NAV/Share(Rs) 29.45 48.75 86.51 96.5 113.08 157.4 171.85 219.76 242.89 250.75
Core EBITDA Margin(%) 26.08 22.53 21.85 18.56 24.41 23.87 28.39 26.93 25.81 27.58
EBIT Margin(%) 24.55 21.1 18.59 17.96 22.11 20.79 23.53 23.12 22.45 21.58
Pre Tax Margin(%) 17.59 14.33 14.34 13.1 13.55 12.33 20.66 19.21 16.39 13.77
PAT Margin (%) 13.97 11.14 11.64 10.01 10.06 8.67 14.17 13.54 11.35 11.13
Cash Profit Margin (%) 18.09 16.07 16.77 14.5 15.49 15.04 19.77 17.97 16.75 18.25
ROA(%) 8.86 6.25 4.88 4.32 3.55 3.54 5.86 6.5 4 3.24
ROE(%) 28.96 17.79 11.8 10.97 10.15 6.58 9.24 10.62 6.66 5.9
ROCE(%) 17.59 13.33 8.76 8.7 9.03 10 11.27 13.03 9.54 7.8
Receivable days 25.98 45.36 76.82 76.05 86.3 75.39 82.53 79.2 123.04 166.77
Inventory Days 90.26 104.4 146.76 133.88 169.92 177.63 230.37 204.46 245.81 318.37
Payable days 103.89 127.57 132.91 96.46 176.8 177.56 210.87 142.76 219.15 299.36
PER(x) 0 0 0 0 0 69.71 54.18 51.36 74.17 89.8
Price/Book(x) 0 0 0 0 0 3.12 4.79 3.93 3.58 3.04
Dividend Yield(%) 0 0 0 0 0 0.1 0.18 0.29 0.14 0.1
EV/Net Sales(x) 1.09 1.24 1.46 1.47 1.64 6.16 8.22 5.94 6.96 6.66
EV/Core EBITDA(x) 3.59 4.38 6.16 6.55 5.97 22.67 28.29 21.62 24.99 23.22
Net Sales Growth(%) 0 0.18 18.89 46.31 5.46 53.32 32.42 49.19 -7.92 -2.58
EBIT Growth(%) 0 -12.1 -3.25 41.35 29.82 44.15 49.92 46.56 -10.56 -6.38
PAT Growth(%) 0 -18.43 14.67 25.86 5.97 32.12 116.48 42.49 -22.79 -4.46
EPS Growth(%) 0 -18.43 17.44 20.53 8.04 -33.89 115.78 10.86 -30.39 -27.51
Debt/Equity(x) 1.89 1.25 0.95 1.32 1.38 0.25 0.46 0.33 0.38 0.48
Current Ratio(x) 0.94 1.49 1.27 1.25 1.12 2.56 2.43 2.6 1.69 1.42
Quick Ratio(x) 0.47 0.81 0.62 0.67 0.52 1.42 0.98 1.46 0.89 0.62
Interest Cover(x) 3.53 3.12 4.38 3.7 2.58 2.46 8.2 5.91 3.7 2.76
Total Debt/Mcap(x) 0 0 0 0 0 0.08 0.1 0.08 0.11 0.16

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -3% +10% +22%
Operating Profit CAGR 0% +10% +23%
PAT CAGR -4% +2% +25%
Share Price CAGR +27% +6% +11%
ROE Average +6% +8% +8% +12%
ROCE Average +8% +10% +10% +11%

Anupam Rasayan India Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 59.07 %
FII 6.91 %
DII (MF + Insurance) 0.35 %
Public (retail) 40.93 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 61.4161.2661.2361.2361.1861.1861.1859.0759.0759.07
FII 9.138.077.147.017.456.464.947.637.66.91
DII 2.512.562.572.32.32.252.241.380.420.35
Public 38.5938.7438.7738.7738.8238.8238.8240.9340.9340.93
Others 0000000000
Total 100100100100100100100100100100

Anupam Rasayan India Peer Comparison

Chemicals Edit Columns

Anupam Rasayan India Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Anupam Rasayan India Pros & Cons

Pros

  • Company has delivered good profit growth of 24% CAGR over last 5 years
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 8% over the last 3 years.
  • Debtor days have increased from 219.15 to 299.36days.
  • Stock is trading at 4.6 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp